hematoxylin has been researched along with Hepatitis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, ZG; Gu, WZ; Huang, SJ; Li, FB; Peng, KR; Shu, XL; Tou, JF; Zhao, H | 1 |
ARTERBERRY, JD; DREXLER, E; DUBOIS, EL | 1 |
Anselmucci, V; Bianchini, G; Casini, A; Gentilini, P; Ramarli, D; Salvadori, G; Surrenti, C | 1 |
3 other study(ies) available for hematoxylin and Hepatitis
Article | Year |
---|---|
Expression of transforming growth factor-β1 and connective tissue growth factor in congenital biliary atresia and neonatal hepatitis liver tissue.
Topics: Biliary Atresia; Cholestasis; Connective Tissue Growth Factor; Disease Progression; Eosine Yellowish-(YS); Epithelial Cells; Female; Gene Expression Regulation; Hematoxylin; Hepatitis; Hepatocytes; Humans; Immunohistochemistry; Infant; Liver Cirrhosis; Male; Transforming Growth Factor beta1 | 2016 |
SIGNIFICANCE OF HEMATOXYLIN BODIES IN LUPUS ERYTHEMATOSUS CELL PREPARATIONS.
Topics: Arthritis; Arthritis, Rheumatoid; Collagen Diseases; Coloring Agents; Diagnosis; Hematoxylin; Hepatitis; Humans; Liver Cirrhosis; Lupus Erythematosus, Systemic; Microscopy; Microscopy, Phase-Contrast; Multiple Myeloma; Neutrophils; Rheumatic Heart Disease; Scleroderma, Systemic; Staining and Labeling | 1964 |
Histochemical, immunological, electron microscopic study in HBsAg patients with liver diseases and healthy carriers.
Topics: Carrier State; Chronic Disease; Eosine Yellowish-(YS); Fluorescent Antibody Technique; Hematoxylin; Hepatitis; Hepatitis B Surface Antigens; Humans; Immunity, Cellular; Liver Diseases; Lymphocyte Activation; Microscopy, Electron; Phytohemagglutinins; Staining and Labeling | 1979 |